Pharmaceutical Policy Reform--Balancing Affordability with Incentives for Innovation

N Engl J Med. 2016 Feb 25;374(8):703-6. doi: 10.1056/NEJMp1515068.

Authors

Rena M Conti¹, Meredith B Rosenthal¹

Affiliation

¹ From the University of Chicago, Chicago (R.M.C.); and the Harvard T.H. Chan School of Public Health, Boston (M.B.R.).

PMID: 26933845
DOI: 10.1056/NEJMp1515068

No abstract available

MeSH terms

Cost Savings / legislation & jurisprudence
Drug Costs / legislation & jurisprudence*
Health Care Reform
Health Policy / legislation & jurisprudence*
Medicare / economics
Medicare / legislation & jurisprudence
Policy Making
Prescription Fees / legislation & jurisprudence
United States